Bioscript Group is one of the largest independent global agencies, with a strong international reputation for high-quality medical communications, regulatory writing and market access consultancy.
The business assists clients in their communications with regulatory authorities as well as educating the medical sector on pharmaceutical products that are in mid- to late-stage clinical trials and subsequently supporting these products, post-market launch, to maintain and grow sales throughout the lifecycle of the drug.
Acquisitions to date:
- Fortis Pharma Consulting, a medical affairs services provider that works with clients in refining and articulating a product’s value at launch
- Valid Insight, an award-winning market access consultancy that helps clients to deliver pricing, reimbursement, market access and payer value communication strategies through the full product development cycle
- Meridian HealthComms, a successful operator with particular strengths in scientific and clinical communications, strategic planning and brand management
The acquisitions have strengthened Bioscript's end-to-end service offering by extending the breadth and depth of its services across the pharmaceutical product lifecycle, and have brought additional capabilities in medical affairs, global market access strategy and payer value communications.
The combined group brings together more than 220 dedicated experts in healthcare communications globally with a focus on scientific and writing excellence, expert engagement, events management, strategic planning and patient access consulting for pharmaceutical and biotech companies.
Today the Group also provides clients with extended support across integrated medical communication programmes, from very early clinical development through to market access communications.
Sovereign is working with the management team to further develop and grow the business.
Back to Investments
